Últimos Artículos de Terapeuthic Advances in Endocrinolgy and Metabolism
- Comparing the efficacy and safety of weekly somatrogon with daily somatropin to treat children with growth hormone deficiency: a plain language summary of publication
- Multi-target gene therapy AUP1602-C to improve healing and quality of life for diabetic foot ulcer patients: a phase I, open-label, dose-finding study
- Understanding the burden of weekly somatrogon injections compared with daily somatropin injections in children with growth hormone deficiency: a plain language summary of publication
- Comparing quality of life in traditional face-to-face visits with a hybrid approach of telemedicine with in-person follow-ups in recent users of advanced closed-loop systems: a randomized controlled clinical trial in patients with type 1 diabetes
- Measurement of salivary thyroid hormones using the LC-MS/MS technique in a clinical setting
- Excessive or sustained endoplasmic reticulum stress: one of the culprits of adipocyte dysfunction in obesity
- Noninsulin antidiabetic prescription patterns in Colombia: a cross-sectional study
- Amputation versus circular external fixation in the treatment of diabetic foot with osteomyelitis: a cost and quality-of-life analysis
- Growth hormone treatment in children with Prader–Willi syndrome: safety and effectiveness data from the PATRO Children study
- Sex-specific impact of GCKR rs1260326 polymorphism on metabolic traits in an older Japanese population: the Bunkyo Health Study
- Metabolic-associated fatty liver disease and pregnancy complications: new challenges and clinical perspectives
- Analyzing and evaluating the prevalence and metabolic profile of lean NAFLD compared to obese NAFLD: a systemic review and meta-analysis
- Glycaemic outcomes in people living with diabetes under 65 and over 65 years old using an intermittently scanned continuous glucose monitoring system
- ANDROID and A/G ratio are correlated with sarcopenia among type 2 diabetes patients
- Diabetes and gout: another role for SGLT2 inhibitors?
- Chronic kidney disease combined with metabolic syndrome is a non-negligible risk factor
- Remote myocardial zone characteristics in type 2 diabetes patients with prior myocardial infarction and comparisons with diabetes patients with no prior infarction
- HbA1c overestimates the glucose management indicator: a pilot study in patients with diabetes, chronic kidney disease not on dialysis, and anemia using isCGM
- Quitting smoking as a probable trigger for new-onset hypothyroidism after successful medical treatment of Graves’ disease: case report
- MAFLD: an ideal framework for understanding disease phenotype in individuals of normal weight